Disulfide Bond Formation in the Periplasm of Escherichia coli
EcoSal Plus · 31.12.2019 · 8 (2)
DOI: 10.1128/ecosalplus.esp-0012-2018 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift EcoSal Plus, erschienen am 31.12.2019. Verfasst von Bruno Manta und 2 weiteren Autor:innen. Beteiligte Einrichtung: New England Biolabs, Ipswich, MA 01938. Hauptthemen laut MEDLINE: Disulfides. Die Arbeit wurde bisher 73-mal zitiert (Crossref) und nennt 188 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
The formation of disulfide bonds is critical to the folding of many extracytoplasmic proteins in all domains of life. With the discovery in the early 1990s that disulfide bond formation is catalyzed by enzymes, the field of oxidative folding of proteins was born. Escherichia coli played a central role as a model organism for the elucidation of the disulfide bond-forming machinery. Since then, many of the enzymatic players and their mechanisms of forming, breaking, and shuffling disulfide bonds have become understood in greater detail. This article summarizes the discoveries of the past 3 decades, focusing on disulfide bond formation in the periplasm of the model prokaryotic host E. coli .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- New England Biolabs, Ipswich, MA 01938.
- Department of Microbiology and Molecular Genetics, Harvard Medical School, Boston, MA 02115.
Zitieren
APA
Manta, B., Boyd, D., & Berkmen, M. (2019). Disulfide Bond Formation in the Periplasm of Escherichia coli. EcoSal Plus, 8(2). https://doi.org/10.1128/ecosalplus.esp-0012-2018
Vancouver
Manta B, Boyd D, Berkmen M. Disulfide Bond Formation in the Periplasm of Escherichia coli. EcoSal Plus. 2019;8(2). doi:10.1128/ecosalplus.esp-0012-2018
BibTeX
@article{Manta2019,
author = {Manta, Bruno and Boyd, Dana and Berkmen, Mehmet},
title = {Disulfide Bond Formation in the Periplasm of Escherichia coli},
journal = {EcoSal Plus},
year = {2019},
volume = {8},
number = {2},
doi = {10.1128/ecosalplus.esp-0012-2018}
}
EUVIMED